Welcome to LookChem.com Sign In|Join Free

CAS

  • or

261924-94-1

Post Buying Request

261924-94-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

261924-94-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 261924-94-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,9,2 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 261924-94:
(8*2)+(7*6)+(6*1)+(5*9)+(4*2)+(3*4)+(2*9)+(1*4)=151
151 % 10 = 1
So 261924-94-1 is a valid CAS Registry Number.

261924-94-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(methylsulfonylmethyl)-benzoic acid

1.2 Other means of identification

Product number -
Other names 3-[(methylsulfonyl)methyl]benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:261924-94-1 SDS

261924-94-1Downstream Products

261924-94-1Relevant articles and documents

NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS

-

Page/Page column 16, (2012/01/15)

Disclosed are quinoline esters of Formula (I): which are useful as Liver X receptors (LXR) modulators. Pharmaceutical compositions containing quinoline esters of Formula (I) and the use of quinoline esters of Formula (I) in the safe treatment of various s

Pyridyl inhibitors of hedgehog signalling

-

Page/Page column 117, (2010/10/20)

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.

Azetidine derivatives, their preparation and medicaments containing them

-

, (2008/06/13)

The invention concerns compounds of formula (1) wherein: R represents a chain (A) or (B); R1 is methyl or ethyl; R2 is either an optionally substituted aromatic or an optionally substituted heteroaromatic ring; R3 and R4, identical or different, are either an optionally substituted aromatic or an optionally substituted heteroaromatic ring; R′ represents a hydrogen atom or a —CO—alk radical, their optical isomers, their salts, their preparation and medicines containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 261924-94-1